- Patent Title: N-link hydroxamic acid derivatives useful as antibacterial agents
-
Application No.: US14447788Application Date: 2014-07-31
-
Publication No.: US09018384B2Publication Date: 2015-04-28
- Inventor: Matthew Frank Brown , Ye Che , Anthony Marfat , Michael Joesph Melnick , Justin Ian Montgomery , Usa Reilly
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D401/00 ; C07D213/64 ; C07D401/04 ; C07D401/08 ; C07D401/10 ; C07D401/12 ; C07D405/04 ; C07D405/10 ; C07D409/04 ; C07D413/10 ; C07D413/12 ; C07D417/04 ; C07D417/10 ; C07D417/12 ; C07D211/86 ; C07D403/04 ; C07D401/14
Abstract:
The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
Public/Granted literature
- US20140343031A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents Public/Granted day:2014-11-20
Information query
